PS-014 Safety analysis of ledipasvir/sofosbuvir, with or without ribavirin, in patients with chronic hepatitis C virus infection: Adverse events and drug interactions
PS-014 Safety analysis of ledipasvir/sofosbuvir, with or without ribavirin, in patients with chronic hepatitis C virus infection: Adverse events and drug interactions